DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

A sheet of cannabis marijuana in the defocus with the image of the formula CBD

The U.S. Drug Enforcement Administration has taken some cannabidiol out of the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.

The DEA announced Thursday that drugs including CBD with THC content below 0.1% are now considered Schedule 5 drugs, as long as they have been approved by the U.S. Food and Drug Administration.

It is the first time the agency has lowered any type of cannabis from Schedule 1.

Continue reading “DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access”

When To Use Cannabis as a Substitute for Pharmaceuticals

wvp2

Medical marijuana advocates have celebrated cannabis as a non-toxic, non-addictive alternative to a wide range of prescription drugs. But while scores of patients have had success using cannabis as a substitute for pharmaceuticals, it’s not for everybody.

For one, not every patient responds to cannabis in the same way. Though many have reported using cannabis to alleviate anxiety, for example, others experience heightened anxiety and paranoia when they smoke weed.

Continue reading “When To Use Cannabis as a Substitute for Pharmaceuticals”